1. Zhang Y, Dai Y, Zheng T, Ma S: Risk factors of non-Hodgkin lymphoma. Expert Opin Med Diagn. 2011, 5: 539-550. 10.1517/17530059.2011.618185.
2. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Wanke RA: Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992, 16: 637-640. 10.1097/00000478-199207000-00001.
3. Hankin RC, Hunter SV: Mantle cell lymphoma. Arch Pathol Lab Med. 1999, 123 (12): 1182-1188.
4. Zhou Y, Wang H, Fang W, Romaguer JE, Zhang Y, Delasalle KB, Kwak L, Yi Q, Du XL, Wang M: Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer. 2008, 113 (4): 791-798. 10.1002/cncr.23608.
5. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA: SEER Cancer Statistics Review 1975–2009. 2012, Bethesda, MD: National Cancer Institute, Based on November 2010 SEER data submission